Abstract
Thoracic aortic aneurysm (TAA) is a common disease affecting between 1% and 3% of the United States population over the age of 50, which is characterized by enlargement of the largest artery in the body (i.e., the thoracic aorta) as a result of weakening of the aortic wall.1 TAA is a largely silent disease until potentially fatal complications, such as rupture, occur. Patients with TAA undergo regular surveillance imaging using computed tomography angiography (CTA) to monitor the overall size of their aneurysm and to detect growth, assessments that in turn determine the need for surgical repair.2 Aortic diameter measurements are used to assess TAA, with measurements performed on volumetric CTA imaging data by manual analysts (i.e., technologists or the physicians themselves) using dedicated three-dimensional (3D) image rendering software. Diameter measurements are made in standardized anatomic locations along the length of the aorta to minimize measurement variability and ensure comparability of measurements across time.3,4

This publication has 22 references indexed in Scilit: